Cryptococcus neoformans Yop1, an endoplasmic reticulum curvature-stabilizing protein, participates with Sey1 in influencing fluconazole-induced disomy formation

FEMS Yeast Research

Volumn 12, Issue 7, 2012, Pages 748-754

  Ngamskulrungroj, Popchai ^a,b   Chang, Yun ^a   Hansen, Bryan ^c   Bugge, Cliff ^d   Fischer, Elizabeth ^c   Kwon Chung, Kyung J ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d Thermo Fisher Scientific   (United States)

Author keywords

Antifungal resistance; Cryptococcus neoformans; Disomy formation; Endoplasmic reticulum; Fluconazole; Heteroresistance

Indexed keywords

FLUCONAZOLE; FUNGAL PROTEIN; PROTEIN SEY1; PROTEIN YOP1; UNCLASSIFIED DRUG;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CHROMOSOME 1; CHROMOSOME 4; CHROMOSOME 7; CHROMOSOME DUPLICATION; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DISOMY; DRUG TOLERANCE; ENDOPLASMIC RETICULUM; FUNGAL GENE; FUNGAL STRAIN; GENE AMPLIFICATION; GENE DELETION; GENETIC CODE; NONHUMAN; PHENOTYPE; PROTEIN PROTEIN INTERACTION; SEY1 GENE; YOP1 GENE;

ANEUPLOIDY; ANTIFUNGAL AGENTS; CRYPTOCOCCUS NEOFORMANS; DRUG RESISTANCE, FUNGAL; ENDOPLASMIC RETICULUM; FLUCONAZOLE; FUNGAL PROTEINS; GENE AMPLIFICATION; GENE DELETION;

FILOBASIDIELLA NEOFORMANS;

EID: 84867659787     PISSN: 15671356     EISSN: 15671364     Source Type: Journal    
DOI: 10.1111/j.1567-1364.2012.00824.x     Document Type: Article

References (29)

1. Akins RA (2005) An update on antifungal targets and mechanisms of resistance in Candida albicans. Med Mycol 43: 285-318.
2. Brands A & Ho TH (2002) Function of a plant stress-induced gene, HVA22. Synthetic enhancement screen with its yeast homolog reveals its role in vesicular traffic. Plant Physiol 130: 1121-1131.
3. Csordas G, Renken C, Varnai P, Walter L, Weaver D, Buttle KF, Balla T, Mannella CA & Hajnoczky G (2006) Structural and functional features and significance of the physical linkage between ER and mitochondria. J Cell Biol 174: 915-921.
4. Davidson RC, Cruz MC, Sia RA, Allen B, Alspaugh JA & Heitman J (2000) Gene disruption by biolistic transformation in serotype D strains of Cryptococcus neoformans. Fungal Genet Biol 29: 38-48.
5. English AR, Zurek N & Voeltz GK (2009) Peripheral ER structure and function. Curr Opin Cell Biol 21: 596-602.
6. Hu J, Shibata Y, Zhu PP et al. (2009) A class of dynamin-like GTPases involved in the generation of the tubular ER network. Cell 138: 549-561.
7. Hu J, Prinz WA & Rapoport TA (2011) Weaving the web of ER tubules. Cell 147: 1226-1231.
8. Kwon-Chung KJ, Sorrell TC, Dromer F, Fung E & Levitz SM (2000) Cryptococcosis: clinical and biological aspects. Med Mycol 38(Suppl 1): 205-213.
9. Mondon P, Petter R, Amalfitano G, Luzzati R, Concia E, Polacheck I & Kwon-Chung KJ (1999) Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans. Antimicrob Agents Chemother 43: 1856-1861.
10. Ngamskulrungroj P, Chang Y, Hansen B, Bugge C, Fischer E & Kwon-Chung KJ (2012) Characterization of the chromosome 4 genes that affect fluconazole-induced disomy formation in Cryptococcus neoformans. PLoS ONE 7: e33022.
11. Niwa O, Tange Y & Kurabayashi A (2006) Growth arrest and chromosome instability in aneuploid yeast. Yeast 23: 937-950.
12. Perfect JR, Ketabchi N, Cox GM, Ingram CW & Beiser CL (1993) Karyotyping of Cryptococcus neoformans as an epidemiological tool. J Clin Microbiol 31: 3305-3309.
13. Perfect JR, Dismukes WE, Dromer F et al. (2010) Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis 50: 291-322.
14. Posteraro B, Sanguinetti M, Sanglard D et al. (2003) Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to fluconazole. Mol Microbiol 47: 357-371.
15. Puhka M, Vihinen H, Joensuu M & Jokitalo E (2007) Endoplasmic reticulum remains continuous and undergoes sheet-to-tubule transformation during cell division in mammalian cells. J Cell Biol 179: 895-909.
16. Rodero L, Mellado E, Rodriguez AC et al. (2003) G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate. Antimicrob Agents Chemother 47: 3653-3656.
17. Schmitt HD (2010) Dsl1p/Zw10: common mechanisms behind tethering vesicles and microtubules. Trends Cell Biol 20: 257-268.
18. Schulz TA & Prinz WA (2007) Sterol transport in yeast and the oxysterol binding protein homologue (OSH) family. Biochim Biophys Acta 1771: 769-780.
19. Shibata Y, Voeltz GK & Rapoport TA (2006) Rough sheets and smooth tubules. Cell 126: 435-439.
20. Sionov E, Chang YC, Garraffo HM & Kwon-Chung KJ (2009) Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence. Antimicrob Agents Chemother 53: 2804-2815.
21. Sionov E, Lee H, Chang YC & Kwon-Chung KJ (2010) Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes. PLoS Pathog 6: e1000848.
22. Sionov E, Chang YC, Garraffo HM, Dolan MA, Ghannoum MA & Kwon-Chung KJ (2012) Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14alpha-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/posaconazole. Antimicrob Agents Chemother 56: 1162-1169.
23. Sullivan DP, Ohvo-Rekila H, Baumann NA, Beh CT & Menon AK (2006) Sterol trafficking between the endoplasmic reticulum and plasma membrane in yeast. Biochem Soc Trans 34: 356-358.
24. Toffaletti DL, Rude TH, Johnston SA, Durack DT & Perfect JR (1993) Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J Bacteriol 175: 1405-1411.
25. Torres EM, Sokolsky T, Tucker CM, Chan LY, Boselli M, Dunham MJ & Amon A (2007) Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science 317: 916-924.
26. Varma A & Kwon-Chung KJ (2010) Heteroresistance of Cryptococcus gattii to fluconazole. Antimicrob Agents Chemother 54: 2303-2311.
27. Voeltz GK, Prinz WA, Shibata Y, Rist JM & Rapoport TA (2006) A class of membrane proteins shaping the tubular endoplasmic reticulum. Cell 124: 573-586.
28. Washton H (1989) Review of fluconazole: a new triazole antifungal agent. Diagn Microbiol Infect Dis 12: 229S-233S.
29. Yoneda A & Doering TL (2006) A eukaryotic capsular polysaccharide is synthesized intracellularly and secreted via exocytosis. Mol Biol Cell 17: 5131-5140.